other · Food and Drug Administration · Rule · Published 2007-10-05 · Effective 2007-10-05 · 72 FR 56896
Document
Document number
E7-19732
Federal Register citation
72 FR 56896
CFR reference
21 CFR 556
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2007-10-05
Effective date
2007-10-05
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for an increased level of monensin in four-way combination Type C medicated feeds containing ractopamine, melengestrol, monensin, and tylosin for heifers fed in confinement for slaughter, a revision to bacterial pathogen nomenclature, and an increase in liver tolerance.